Atezolizumab,Cabozantinib
Roche
['rcc,(-irccs),(-srcc),(-urcc)', 'atezo', 'cabozantinib']
adding atezolizumab to cabozantinib did not improve outcomes in mrcc pts with prior ici-treatment. first trial of this kind with groundbreaking guideline-changing results! all led by the unique extraordinaire #asco23 
Postdoctoral GU Oncology Research Fellow @DanaFarber | Computational biology enthusiast #BacaLab |
MD, MSc @USJliban